leisure time -WSS

leisure time

author：explore 2025-09-06 03:33:31 - browse：64

An orange Flovent inhaler on a white background. -- health coverage from STAT — Adobe

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years.

Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “authorized generic,” essentially the same product sold under a private label. Prasco, a U.S. drugmaker specializing in authorized generics, will distribute the new inhaler, sold as fluticasone.

The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx, leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. By discontinuing the brand-name inhaler but continuing to earn money from the authorized generic, GSK will be able to avoid paying a penalty.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Gene therapy has helped boys walk. Can scientists keep it that way?

hotspot

WSS

#NeedHerScience: shining a light on gender disparities in medicine

Ahead of JPM, here's who's profiting most in health care

White House finalizes ITC's import ban of latest Apple Watches

Paxlovid study fails to answer questions over benefit for broader groups

Death of patient in Alzheimer’s trial raises question of possible risks

WATCH: Why do fingernails fall off when they're damaged?

focus

leisure time

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

A single drug, study failures leave Anavex with nothing but cash

Activists slam private health insurers over coverage restrictions

New guidelines on severe brain injury complicate already difficult decisions

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Why drug prescriptions should include diagnoses

Anesthesiologist group: stop taking Ozempic before surgery

STAT's guide to the next generation of CAR

Cancer drug shortages should be causing more outrage

Do masks work? RCTs can't tell us

focus

The battle over the Brookhaven Landfill on Long Island

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Videos point to link between seizures and unexplained toddler deaths

New weight loss drugs work. But how can they best be used?

Antibiotic resistance and the global rise in human conflict

hotspot

hotspot

explore

focus